Literature DB >> 31032547

Sequential Photochemical and Prins Reactions for the Diastereoselective Synthesis of Tricyclic Scaffolds.

Bethan L Donnelly1, Luke D Elliott1, Christine L Willis1, Kevin I Booker-Milburn1.   

Abstract

Cyclobutene alcohols undergo Prins cyclisations to generate single diastereomers of novel tricyclic heterocycles with five contiguous stereocentres. The reaction times are significantly shorter (ca. 15 min) than with traditional alkene substrates. Stereoselective aza-Prins cyclisations of cyclobutene amine derivatives give fused aza-heterocyclic scaffolds. Computational studies provide insight into the observed stereocontrol. The modular approach is flexible, enabling the introduction of a variety of functional groups (including amides, nitriles, alkynes, and arenes) into the sp3 -rich heterocyclic scaffolds.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Prins cyclization; Ritter reaction; cyclobutene; fluorination; photochemistry

Year:  2019        PMID: 31032547     DOI: 10.1002/anie.201903488

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  3 in total

1.  Escaping from Flatland: [2 + 2] Photocycloaddition; Conformationally Constrained sp3-rich Scaffolds for Lead Generation.

Authors:  Brian Cox; Kevin I Booker-Milburn; Luke D Elliott; Michael Robertson-Ralph; Victor Zdorichenko
Journal:  ACS Med Chem Lett       Date:  2019-10-22       Impact factor: 4.345

2.  Copper-catalyzed radical cascade reaction of simple cyclobutanes: synthesis of highly functionalized cyclobutene derivatives.

Authors:  Chunyang Liu; Xiaoyan Shangguan; Yan Li; Qian Zhang
Journal:  Chem Sci       Date:  2022-06-10       Impact factor: 9.969

3.  Readily accessible sp3-rich cyclic hydrazine frameworks exploiting nitrogen fluxionality.

Authors:  Conor Dean; Sundaram Rajkumar; Stefan Roesner; Nessa Carson; Guy J Clarkson; Martin Wills; Matthew Jones; Michael Shipman
Journal:  Chem Sci       Date:  2020-01-02       Impact factor: 9.825

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.